Martin Höglund

Second‐ and Third‐Line Salvage Chemotherapy Followed by Allogeneic Stem Cell Transplantation Leads to High Survival Rates in Primary Refractory AML: A Population‐Based Study

Liew‐Littorin, Markus; Deleskog‐Spångberg, Linn; Deneberg, Stefan; Janosi, Judit et al.

Part of European Journal of Haematology, p. 423-432, 2025

DOI for Second‐ and Third‐Line Salvage Chemotherapy Followed by Allogeneic Stem Cell Transplantation Leads to High Survival Rates in Primary Refractory AML: A Population‐Based Study
Download full text (pdf) of Second‐ and Third‐Line Salvage Chemotherapy Followed by Allogeneic Stem Cell Transplantation Leads to High Survival Rates in Primary Refractory AML: A Population‐Based Study

High Prevalence of Psychological Symptoms, Sexual Dysfunction, and Prolonged Medical Leave Two Years After Acute Leukemia Diagnosis-Patient Reported Outcome in Sweden

Lennmyr, Emma; Lübking, Anna; Abrahamsson, Marie; Juliusson, Gunnar et al.

Part of eJHaem, 2025

Reduced Intensity transplantation vs chemotherapy in CR1: A prospective, pseudorandomized study in 50-70 year old AML patients

Brune, Mats; Kiss, Thomas; Anderson, Harald; Nicklasson, Malin et al.

Part of Bone Marrow Transplantation, p. 1676-1682, 2024

Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition

Roeth, Alexander; He, Guangsheng; Tong, Hongyan; Lin, Zenghua et al.

Part of American Journal of Hematology, p. 1768-1777, 2024

Cytarabine dose intensification improves survival in older patients with secondary/high-risk acute myeloid leukemia in matched real-world versus clinical trial data

Abé, Christoph; Keto, Jaana; Lilja, Mathias; Konradsen, Mie et al.

Part of Leukemia and Lymphoma, p. 1493-1501, 2024

Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis

Iribarren, Cristina; Levedahl, Kerstin; Atanasoai, Ionut; Mattsson, Mattias et al.

Part of Journal of Molecular Diagnostics, p. 792-804, 2024

Next generation pan-cancer blood proteome profiling using proximity extension assay

Alvez, Maria Bueno; Edfors, Fredrik; von Feilitzen, Kalle; Zwahlen, Martin et al.

Part of Nature Communications, 2023

The impact of Covid-19 in patients with chronic myeloid leukemia: a nationwide population-based study

Dahlen, Torsten; Flygt, Hjalmar; Lubking, Anna; Olsson-Strömberg, Ulla et al.

Part of Leukemia, p. 1156-1159, 2023

Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children

Stratmann, Svea; Vesterlund, Mattias; Umer, Husen M.; Skaftason, Aron et al.

Part of Leukemia, p. 550-559, 2023

Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications

Nilsson, Christer; Linde, Fredrika; Hulegardh, Erik; Garelius, Hege et al.

Part of Haematologica, p. 1015-1025, 2023

Targeting SAMHD1 with hydroxyurea in first-line cytarabine-based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT-AML trial

Jadersten, Martin; Lilienthal, Ingrid; Tsesmetzis, Nikolaos; Lourda, Magda et al.

Part of Journal of Internal Medicine, p. 925-940, 2022

Cardiovascular disease in patients with chronic lymphocytic leukemia: A Swedish nationwide register study with matched comparators

Larsson, Karin; Soderling, Jonas; Höglund, Martin; Glimelius, Ingrid et al.

Part of American Journal of Hematology, 2022

DOI for Cardiovascular disease in patients with chronic lymphocytic leukemia: A Swedish nationwide register study with matched comparators

Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression

Stratmann, Svea; Yones, Sara A.; Garbulowski, Mateusz; Sun, Jitong et al.

Part of Blood Advances, p. 152-164, 2022

Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls

Sabaa, Amal Abu; Shen, Qiujin; Lennmyr, Emma; Enblad, Anna Pia et al.

Part of New Biotechnology, p. 21-29, 2022

A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias

Berglund, Eva Caroline; Barbany, Gisela; Orsmark-Pietras, Christina; Fogelstrand, Linda et al.

Part of Frontiers in Medicine, 2022

A risk score based on real-world data to predict early death in acute promyelocytic leukemia

Österroos, Albin; Maia, Tania; Eriksson, Anna; Jädersten, Martin et al.

Part of Haematologica, p. 1528-1537, 2022

Noninvasive detection of any-stage cancer using free glycosaminoglycans

Bratulic, Sinisa; Limeta, Angelo; Dabestani, Saeed; Birgisson, Helgi et al.

Part of Proceedings of the National Academy of Sciences of the United States of America, 2022

Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow-up of patients diagnosed 2002-2017 in a complete coverage and nationwide agnostic register study

Dahlen, Torsten; Edgren, Gustaf; Ljungman, Per; Flygt, Hjalmar et al.

Part of American Journal of Hematology, p. 421-430, 2022

IFN-alfa with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia

Huuhtanen, Jani; Ilander, Mette; Yadav, Bhagwan; Dufva, Olli M. J. et al.

Part of Journal of Clinical Investigation, 2022

Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma

Mörth, Charlott; Sabaa, Amal Abu; Freyhult, Eva; Christersson, Christina et al.

Part of Cardio-Oncology, 2021

Increased levels of the cardiovascular disease risk biomarkers GDF15 and myostatin in patients with chronic lymphocytic leukemia

Larsson, Karin; Höglund, Martin; Larsson, Anders; Thulin, Måns et al.

Part of Growth Factors, p. 189-196, 2021

Is there an impact of measurable residual disease as assessed by multiparameter flow cytometry on survival of AML patients treated in clinical practice?: A population-based study

Rosso, Aldana; Juliusson, Gunnar; Lorenz, Fryderyk; Lehmann, Sören et al.

Part of Leukemia and Lymphoma, p. 1973-1981, 2021

Vitamin D levels and busulphan kinetics in patients undergoing hematopoietic stem cell transplantation, a multicenter study

El-Serafi, Ahmed; He, Rui; Zheng, Wenyi; Benkossou, Fadwa et al.

Part of Bone Marrow Transplantation, p. 807-817, 2021

DOI for Vitamin D levels and busulphan kinetics in patients undergoing hematopoietic stem cell transplantation, a multicenter study

Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR-ABL1, a Swedish population-based study

Orsmark-Pietras, Christina; Landberg, Niklas; Lorenz, Fryderyk; Uggla, Bertil et al.

Part of Genes, Chromosomes and Cancer, p. 426-433, 2021

Socioeconomic cost of AML in Sweden-A population-based study using multiple nation-wide registers

Hernlund, Emma; Redig, Josefine; Paulsson, Bjorn; Derolf, Asa Rangert et al.

Part of eJHaem, p. 385-393, 2021

Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets

Stratmann, Svea; Yones, Sara A.; Mayrhofer, Markus; Norgren, Nina et al.

Part of Blood Advances, p. 900-912, 2021

DOI for Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets

Successful tyrosine kinase inhibitor discontinuation outside clinical trials - data from the population-based Swedish chronic myeloid leukaemia registry

Flygt, Hjalmar; Sandin, Fredrik; Dahlén, Torsten; Dremaine, Arta et al.

Part of British Journal of Haematology, p. 915-921, 2021

Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial

Löwenberg, Bob; Pabst, Thomas; Maertens, Johan; Gradowska, Patrycja et al.

Part of Blood Advances, p. 1110-1121, 2021

DOI for Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial

Impact of treatment delay in acute myeloid leukemia revisited

Juliusson, Gunnar; Hagberg, Oskar; Lazarevic, Vladimir Lj; Lehmann, Sören et al.

Part of Blood Advances, p. 787-790, 2021

DOI for Impact of treatment delay in acute myeloid leukemia revisited

Estimation of numbers of mature and immature neutrophils in blood by a novel, rapid and simple technology

Venge, Per; Eriksson, Ann-Katrin; Moberg, Lena; Peterson, Christer et al.

Part of Scandinavian Journal of Clinical and Laboratory Investigation, p. 307-311, 2021

Profiling of donor-specific immune effector signatures in response to rituximab in a human whole blood loop assay using blood from CLL patients

Eltahir, mohmo394; Fletcher, E.; Dynesius, L.; Jarblad, J. L. et al.

Part of International Immunopharmacology, 2021

High prevalence and incidence of cardiovascular disease in chronic lymphocytic leukaemia: a nationwide population-based study

Larsson, Karin; Mattsson, Mattias; Ebrahim, Fereshte; Glimelius, Ingrid et al.

Part of British Journal of Haematology, 2020

DOI for High prevalence and incidence of cardiovascular disease in chronic lymphocytic leukaemia: a nationwide population-based study

Real-world data on treatment patterns and outcomes of hypomethylating therapy in patients with newly diagnosed acute myeloid leukaemia aged ≥ 60 years

Österroos, Albin; Eriksson, Anna; Antunovic, Petar; Cammenga, Jörg et al.

Part of British Journal of Haematology, 2020

DOI for Real-world data on treatment patterns and outcomes of hypomethylating therapy in patients with newly diagnosed acute myeloid leukaemia aged ≥ 60 years

The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia

Pfirrmann, Markus; Clark, Richard E.; Prejzner, Witold; Lauseker, Michael et al.

Part of Leukemia, p. 2138-2149, 2020

Increasing prevalence of chronic lymphocytic leukemia with an estimated future rise: a nationwide population-based study

Mattsson, Mattias; Sandin, Fredrik; Kimby, Eva; Höglund, Martin et al.

Part of American Journal of Hematology, 2020

DOI for Increasing prevalence of chronic lymphocytic leukemia with an estimated future rise: a nationwide population-based study

The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting

Juliusson, Gunnar; Jädersten, Martin; Deneberg, Stefan; Lehmann, Sören et al.

Part of Blood Advances, p. 1094-1101, 2020

DOI for The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting

AroCell TK 210 ELISA for determination of TK1 protein: age-related reference ranges and comparison with other TK1 assays

Kumar, Jagarlamudi Kiran; Holmgren, Sofia; Hamberg Levedahl, Kerstin; Höglund, Martin et al.

Part of BioTechniques, p. 335-342, 2020

Introducing Patient-Reported Outcome in the Acute Leukemia Quality Registries in Sweden

Lennmyr, Emma; Karlsson, Karin; Abrahamsson, Marie; Ebrahim, Feresthe et al.

Part of European Journal of Haematology, p. 571-580, 2020

Increased Risk of Chronic Myeloid Leukemia Following Gastric Conditions Indicating Helicobacter pylori Infection: A Case-Control Study

Larfors, Gunnar; Richter, Johan; Själander, Anders; Stenke, Leif et al.

Part of Cancer Epidemiology, Biomarkers and Prevention, p. 151-156, 2020

DOI for Increased Risk of Chronic Myeloid Leukemia Following Gastric Conditions Indicating Helicobacter pylori Infection: A Case-Control Study

Hypo, Hyper, or Combo: new paradigm for treatment of acute myeloid leukemia in older people

Juliusson, Gunnar; Höglund, Martin; Lehmann, Sören

Part of Haematologica, p. 249-251, 2020

DOI for Hypo, Hyper, or Combo: new paradigm for treatment of acute myeloid leukemia in older people

Decreasing early mortality in acute myeloid leukaemia in Sweden 1997-2014: improving performance status is a major contributing factor

Derolf, Åsa; Juliusson, Gunnar; Benson, Lina; Flöisand, Yngvar et al.

Part of British Journal of Haematology, p. 187-191, 2020

DOI for Decreasing early mortality in acute myeloid leukaemia in Sweden 1997-2014: improving performance status is a major contributing factor

Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry

Lubking, Anna; Dreimane, Arta; Sandin, Fredrik; Isaksson, Cecilia et al.

Part of Bone Marrow Transplantation, p. 1764-1774, 2019

DOI for Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry

Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts

Angenendt, Linus; Röllig, Christoph; Montesinos, Pau; Martinez-Cuadron, David et al.

Part of Journal of Clinical Oncology, p. 2632-2642, 2019

DOI for Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts

Secondary Acute Myeloid Leukemia and the Role of Allogeneic Stem Cell Transplantation in a Population-Based Setting

Nilsson, Christer; Hulegardh, Erik; Garelius, Hege; Mollgard, Lars et al.

Part of Biology of blood and marrow transplantation, p. 1770-1778, 2019

DOI for Secondary Acute Myeloid Leukemia and the Role of Allogeneic Stem Cell Transplantation in a Population-Based Setting

U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.

Glimelius, Bengt; Melin, Beatrice; Enblad, Gunilla; Alafuzoff, Irina et al.

Part of Acta Oncologica, p. 187-194, 2018

A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia

Enblad, Gunilla; Karlsson, Hannah; Gammelgård, Gustav; Wenthe, Jessica et al.

Part of Clinical Cancer Research, p. 6185-6194, 2018

DOI for A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia

Continuous Increasing Prevalence of Chronic Lymphocytic Leukemia (CLL) with an Estimated Future Rise-a Nationwide Population-Based Study from Sweden

Mattsson, Mattias; Sandin, Fredrik; Kimby, Eva; Höglund, Martin et al.

Part of Blood, 2018

DOI for Continuous Increasing Prevalence of Chronic Lymphocytic Leukemia (CLL) with an Estimated Future Rise-a Nationwide Population-Based Study from Sweden

Acute myeloid leukemia in very old patients

Lazarevic, Vladimir Lj; Bredberg, Anders; Lorenz, Fryderyk; Ohlander, Emma et al.

Part of Haematologica, 2018

DOI for Acute myeloid leukemia in very old patients

Validation of the EUTOS long-term survival score in a recent independent cohort of "real world" CML patients

Geelen, Inge G. P.; Sandin, Fredrik; Thielen, Noortje; Janssen, Jeroen J. W. M. et al.

Part of Leukemia, p. 2299-2303, 2018

DOI for Validation of the EUTOS long-term survival score in a recent independent cohort of "real world" CML patients

Towards repositioning of quinacrine for treatment of acute myeloid leukemia - Promising synergies and in vivo effects.

Eriksson, Anna; Chantzi, Efthymia; Fryknäs, Mårten; Gullbo, Joachim et al.

Part of Leukemia Research, p. 41-46, 2017

In vitro and in vivo anti-leukemic activity of the peptidase-potentiated alkylator melflufen in acute myeloid leukemia

Strese, Sara; Hassan, Saadia Bashir; Velander, Ebba; Haglund, Caroline et al.

Part of Oncotarget, p. 6341-6352, 2017

DOI for In vitro and in vivo anti-leukemic activity of the peptidase-potentiated alkylator melflufen in acute myeloid leukemia

Tumor SHB gene expression affects disease characteristics in human acute myeloid leukemia

Jamalpour, Maria; Li, Xiujuan; Cavelier, Lucia; Gustafsson, Karin et al.

Part of Tumor Biology, 2017

The impact of socio-economic factors on treatment choice and mortality in chronic myeloid leukaemia

Larfors, Gunnar; Sandin, Fredrik; Richter, Johan; Själander, Anders et al.

Part of European Journal of Haematology, p. 398-406, 2017

DOI for The impact of socio-economic factors on treatment choice and mortality in chronic myeloid leukaemia

Reply to D. Pulte et al.

Bower, Hannah; Björkholm, Magnus; Dickman, Paul W; Höglund, Martin et al.

Part of Journal of Clinical Oncology, p. 696-697, 2017

DOI for Reply to D. Pulte et al.

Prevalence and characteristics of survivors from acute myeloid leukemia in Sweden

Juliusson, Gunnar; Abrahamsson, J; Lazarevic, V; Antunovic, P et al.

Part of Leukemia, p. 728-731, 2017

DOI for Prevalence and characteristics of survivors from acute myeloid leukemia in Sweden

Treatment and outcome of 2904 CML patients from the EUTOS population-based registry

Hoffmann, V S; Baccarani, M; Hasford, J; Castagnetti, F et al.

Part of Leukemia, p. 593-601, 2017

DOI for Treatment and outcome of 2904 CML patients from the EUTOS population-based registry

Immunological biomarkers correlate to survival in CAR19-treated patients

Lövgren, Tanja; Wenthe, Jessica; Karlsson, S. C. Hannah; Gammelgård, Gustav et al.

Part of Scandinavian Journal of Immunology, p. 337-337, 2017

Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia.

Ilander, M; Olsson-Strömberg, Ulla; Schlums, H; Guilhot, J et al.

Part of Leukemia, p. 1108-1116, 2017

HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia

Kontro, M; Kumar, A; Majumder, M M; Eldfors, S et al.

Part of Leukemia, p. 301-309, 2017

DOI for HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia

Incidence and prognostic significance of isolated trisomies in adult acute myeloid leukemia: A population-based study from the Swedish AML registry

Lazarevic, Vladimir Lj; Rosso, Aldana; Juliusson, Gunnar; Antunovic, Petar et al.

Part of European Journal of Haematology, p. 493-500, 2017

DOI for Incidence and prognostic significance of isolated trisomies in adult acute myeloid leukemia: A population-based study from the Swedish AML registry

Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era: a report from the Swedish CML register

Söderlund, Stina; Dahlén, Torsten; Sandin, Fredrik; Olsson-Strömberg, Ulla et al.

Part of European Journal of Haematology, p. 57-66, 2017

DOI for Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era: a report from the Swedish CML register

Early death rates remain high in high-risk APL: update from the Swedish Acute Leukemia Registry 1997-2013

Lehmann, Sören; Deneberg, S.; Antunovic, P.; Rangert-Derolf, A. et al.

Part of Leukemia, p. 1457-1459, 2017

DOI for Early death rates remain high in high-risk APL: update from the Swedish Acute Leukemia Registry 1997-2013

Utility of bronchoalveolar lavage in diagnosing respiratory tract infections in patients with hematological malignancies: are invasive diagnostics still needed?

Svensson, Tobias; Lundström, Kristina Lamberg; Höglund, Martin; Cherif, Honar

Part of Upsala Journal of Medical Sciences, p. 56-60, 2017

No increased prevalence of malignancies among first-degree relatives of 800 patients with chronic myeloid leukemia: a population-based study in Sweden

Gunnarsson, N.; Höglund, Martin; Stenke, L.; Sandin, F. et al.

Part of Leukemia, p. 1825-1827, 2017

DOI for No increased prevalence of malignancies among first-degree relatives of 800 patients with chronic myeloid leukemia: a population-based study in Sweden

A Population-Based Study on First AML Relapse in Sweden

Olsson, Richard; Höglund, Martin; Juliusson, G.

Part of Annals of Hematology, 2017

Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations

Ljungström, Viktor; Cortese, Diego; Young, Emma; Pandzic, Tatjana et al.

Part of Blood, p. 1007-1016, 2016

DOI for Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations

Combination screening in vitro identifies synergistically acting KP372-1 and cytarabine against acute myeloid leukemia

Österroos, Albin; Kashif, Muhammad; Haglund, Caroline; Blom, Kristin et al.

Part of Biochemical Pharmacology, p. 40-49, 2016

DOI for Combination screening in vitro identifies synergistically acting KP372-1 and cytarabine against acute myeloid leukemia

CD19-targeting third generation CAR T cells for relapsed and refractory lymphoma and leukemia: report from the Swedish phase Ulla trial

Enblad, Gunilla; Karlsson, Hannah; Wikström, Kristina I.; Essand, Magnus et al.

Part of CANCER IMMUNOLOGY RESEARCH, 2016

DOI for CD19-targeting third generation CAR T cells for relapsed and refractory lymphoma and leukemia: report from the Swedish phase Ulla trial

Safety and efficacy of the combination of pegylated interferon-alpha 2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients

Hjorth-Hansen, H.; Stentoft, J.; Richter, J.; Koskenvesa, P. et al.

Part of Leukemia, p. 1853-1860, 2016

DOI for Safety and efficacy of the combination of pegylated interferon-alpha 2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients

Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalence

Gunnarsson, Niklas; Sandin, Fredrik; Höglund, Martin; Stenke, Leif et al.

Part of European Journal of Haematology, p. 387-392, 2016

DOI for Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalence

Repositioning Of Quinacrine For Treatment Of Acute Myeloid Leukemia - Synergies And In Vivo Effects

Eriksson, Anna; Gustafsson, Mats; Fryknäs, Mårten; Gullbo, Joachim et al.

Part of Haematologica, p. 367-368, 2016

A Clinical Trial Using Third Generation CD19 Targeting CAR T Cells for Relapsed Lymphoma and Leukemia

Enblad, Gunilla; Karlsson, Hannah; Wenthe, Jessica; Wikström, Kristina I. et al.

Part of Molecular Therapy, 2016

Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia

Gunnarsson, N.; Höglund, Martin; Stenke, L.; Wallberg-Jonsson, S. et al.

Part of Leukemia, p. 1562-1567, 2016

DOI for Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia

Cardiovascular Events Associated With Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Population-Based Cohort Study

Dahlen, Torsten; Edgren, Gustaf; Lambe, Mats; Höglund, Martin et al.

Part of Annals of Internal Medicine, p. 161-166, 2016

DOI for Cardiovascular Events Associated With Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Population-Based Cohort Study

Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population

Bower, Hannah; Björkholm, Magnus; Dickman, Paul W; Höglund, Martin et al.

Part of Journal of Clinical Oncology, p. 2851-2858, 2016

DOI for Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population

Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis

Mosrati, Mohamed Ali; Willander, Kerstin; Falk, Ingrid Jakobsen; Hermanson, Monica et al.

Part of Oncotarget, p. 25109-25120, 2015

Download full text (pdf) of Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis

Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia

Eriksson, Anna; Österroos, Albin; Hassan, Sadia Bashir; Gullbo, Joachim et al.

Part of Blood Cancer Journal, 2015

DISSECTING RESISTANCE MECHANISMS IN CHRONIC LYMPHOCYTIC LEUKEMIA USING WHOLE-EXOME SEQUENCING: IMPACT OF RECURRENT RPS15 MUTATIONS ON P53 DYSREGULATION

Ljungström, Viktor; Cortese, Diego; Young, Emma; Pandzic, Tatjana et al.

Part of Haematologica, p. 10-11, 2015

The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce Myeloid Suppressor Cells and Release Effector Lymphocyte Responses

Christiansson, Lisa; Söderlund, Stina; Mangsbo, Sara; Hjorth-Hansen, Henrik et al.

Part of Molecular Cancer Therapeutics, p. 1181-1191, 2015

DOI for The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce Myeloid Suppressor Cells and Release Effector Lymphocyte Responses

Leukemia and Myelodysplastic Syndrome in Granulomatosis with Polyangiitis: Subtypes, Clinical Characteristics, and Outcome

Knight, Ann; Hjorton, Karin; Sundström, Christer; Höglund, Martin et al.

Part of Journal of Rheumatology, p. 690-694, 2015

DOI for Leukemia and Myelodysplastic Syndrome in Granulomatosis with Polyangiitis: Subtypes, Clinical Characteristics, and Outcome

Failure matters: unsuccessful cytogenetics and unperformed cytogenetics are associated with a poor prognosis in a population-based series of acute myeloid leukaemia

Lazarevic, Vladimir; Hörstedt, Ann-Sofi; Johansson, Bertil; Antunovic, Petar et al.

Part of European Journal of Haematology, p. 419-423, 2015

DOI for Failure matters: unsuccessful cytogenetics and unperformed cytogenetics are associated with a poor prognosis in a population-based series of acute myeloid leukaemia

Characterization and prognostic features of secondary acute myeloid leukemia (AML) in a population-based setting: A report from the Swedish Acute Leukemia Registry

Hulegårdh, Erik; Nilsson, Christer; Lazarevic, Vladimir; Garelius, Hege et al.

Part of American Journal of Hematology, p. 208-214, 2015

DOI for Characterization and prognostic features of secondary acute myeloid leukemia (AML) in a population-based setting: A report from the Swedish Acute Leukemia Registry

Real-world cost-effectiveness in chronic myeloid leukemia: the price of success during four decades of development from non-targeted treatment to imatinib

Ohm, Lotta; Lundqvist, Adam; Dickman, Paul; Höglund, Martin et al.

Part of Leukemia and Lymphoma, p. 1385-1391, 2015

DOI for Real-world cost-effectiveness in chronic myeloid leukemia: the price of success during four decades of development from non-targeted treatment to imatinib

Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006)

Hjorth-Hansen, Henrik; Stenke, Leif; Söderlund, Stina; Dreimane, Arta et al.

Part of European Journal of Haematology, p. 243-250, 2015

Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era

Gunnarsson, Niklas; Stenke, Leif; Höglund, Martin; Sandin, Fredrik et al.

Part of British Journal of Haematology, p. 683-688, 2015

DOI for Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era

Prognostic significance of high hyperdiploid and triploid/tetraploid adult acute myeloid leukemia

Lazarevic, Vladimir; Rosso, Aldana; Juliusson, Gunnar; Antunovic, Petar et al.

Part of American Journal of Hematology, p. 800-805, 2015

DOI for Prognostic significance of high hyperdiploid and triploid/tetraploid adult acute myeloid leukemia

PROGRESSION OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA TO ADVANCED PHASE ON TKI THERAPY: A POPULATION BASED ANALYSIS FROM THE SWEDISH CML REGISTER

Söderlund, Stina; Dahlen, T.; Creignou, M.; Sandin, F. et al.

Part of Haematologica, p. 233-233, 2015

Third Generation CD19-CAR T Cells for Relapsed and Refractory Lymphoma and Leukemia Report from the Swedish Phase I/IIa Trial

Enblad, Gunilla; Karlsson, Hannah; Wikström, Kristina; Essand, Magnus et al.

Part of Blood, 2015

Mature, Adaptive-like CD56(DIM) NK Cells in Chronic Myeloid Leukemia Patients in Treatment Free Remission

Ilander, Mette; Schlums, Heinrich; Olsson-Strömberg, Ulla; Lahteenmaki, Hanna et al.

Part of Blood, 2015

Safety and Efficacy of Addition of Pegylated Interferon alpha2b to Standard Dose Dasatinib in Newly Diagnosed Chronic Phase CML Patients

Hjorth-Hansen, Henrik; Stentoft, Jesper; Richter, Johan; Koskenvesa, Perttu et al.

Part of Blood, 2015

Increased Prevalence of Prior Malignancies and Autoimmune Diseases in Patients Diagnosed with Chronic Myeloid Leukemia

Gunnarsson, Niklas; Höglund, Martin; Stenke, Leif; Jonsson, Solveig Wallberg et al.

Part of Blood, 2015

Prevalence and Characteristics of Survivors from Adult Acute Myeloid Leukemia (AML) in Sweden 2014

Juliusson, Gunnar; Lazarevic, Vladimir; Antunovic, Petar; Derolf, Asa Rangert et al.

Part of Blood, 2015

Reasons for Decreasing Early Mortality in Acute Myeloid Leukemia: An Epidemiological Study from the Swedish Acute Leukemia Registry

Deneberg, Stefan; Lundin, Ebba; Lazarevic, Vladimir; Benson, Lina et al.

Part of Blood, 2015

Temporal Trends in Chronic Myeloid Leukemia Outcome Using the Loss in Expectation of Life: A Swedish Population-Based Study

Björkholm, Magnus; Bower, Hannah; Dickman, Paul W.; Lambert, Paul C. et al.

Part of Blood, 2015

Association of TERT polymorphism with acute myeloid leukemia risk and prognosis

Lotfi, Kourosh; Mosrati, Mohamed Ali; Willander, Kerstin; Falk, Ingrid Jakobsen et al.

Part of Cancer Research, 2015

DOI for Association of TERT polymorphism with acute myeloid leukemia risk and prognosis

Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by DNMT3A mutational status and associated with predominant hypomethylation of HOX genes

Qu, Ying; Lennartsson, Andreas; Gaidzik, Verena I.; Deneberg, Stefan et al.

Part of Epigenetics, p. 1108-1119, 2014

DOI for Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by DNMT3A mutational status and associated with predominant hypomethylation of HOX genes

Incidence and prognostic significance of karyotypic subgroups in older patients with acute myeloid leukemia: the Swedish population-based experience

Lazarevic, V.; Horstedt, A-S; Johansson, B.; Antunovic, P. et al.

Part of Blood Cancer Journal, 2014

AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and a dose dependent reduction of kinase activity in acute myeloid leukemia

Eriksson, Anna; Kalushkova, Antonia; Jarvius, Malin; Hilhorst, Riet et al.

Part of Biochemical Pharmacology, p. 284-291, 2014

Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence

Genovese, Giulio; Kaehler, Anna K.; Handsaker, Robert E.; Lindberg, Johan et al.

Part of New England Journal of Medicine, p. 2477-2487, 2014

DOI for Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence

Disease Relapse After Tyrosine Kinase Inhibitor Treatment Discontinuation in Chronic Myeloid Leukaemia is Related to Both Low Number and Impaired Function of NK Cells

Ilander, Mette; Olsson-Strömberg, Ulla; Lahteenmaki, Hanna; Kasanen, Tiina et al.

Part of Scandinavian Journal of Immunology, p. 467-468, 2014

Economic Evaluation of Posaconazole Versus Fluconazole or Itraconazole in the Prevention of Invasive Fungal Infection in High-Risk Neutropenic Patients in Sweden

Lundberg, Johan; Höglund, Martin; Bjorkholm, Magnus; Akerborg, Orjan

Part of Clinical drug investigation, p. 483-489, 2014

DOI for Economic Evaluation of Posaconazole Versus Fluconazole or Itraconazole in the Prevention of Invasive Fungal Infection in High-Risk Neutropenic Patients in Sweden

Impact of ABCB1 single nucleotide polymorphisms 1236C>T and 2677G>T on overall survival in FLT3 wild-type de novo AML patients with normal karyotype

Falk, Ingrid Jakobsen; Fyrberg, Anna; Paul, Esbjorn; Nahi, Hareth et al.

Part of British Journal of Haematology, p. 671-680, 2014

DOI for Impact of ABCB1 single nucleotide polymorphisms 1236C>T and 2677G>T on overall survival in FLT3 wild-type de novo AML patients with normal karyotype

Increased Risk of Cardiovascular Events Associated with TKI Treatment in Chronic Phase Chronic Myeloid Leukemia. Data from Swedish Population-Based Registries

Dahlen, Torsten; Edgren, Gustaf; Höglund, Martin; Lambe, Mats et al.

Part of Blood, 2014

Targeted RNA Sequencing Assay Efficiently Identifies Cryptic KMT2A (MLL)-Fusions in Acute Leukemia Patients

Sevov, Marie; Bunikis, Ignas; Häggqvist, Susana; Höglund, Martin et al.

Part of Blood, 2014

Incidence of CML in Europe -- a Comparison of 19 European Countries with US SEER Data

Hoffmann, Verena S.; Lindoerfer, Doris; Thaler, Josef; Boris, Labar et al.

Part of Blood, 2014

Early Disease Relapse after Tyrosine Kinase Inhibitor Treatment Discontinuation in CML Is Related Both to Low Number and Impaired Function of NK-Cells

Ilander, Mette Matilda; Olsson-Strömberg, Ulla; Lahteenmaki, Hanna; Tiina, Kasanen et al.

Part of Blood, 2014

Improved Survival of Patients with Acute Myeloid Leukemia Following Implementation of Swedish National Guidelines: Results from the AML Registry 1997-2013

Juliusson, Gunnar; Lazarevic, Vladimir; Lehmann, Soren; Derolf, Asa Rangert et al.

Part of Blood, 2014

Repositioning of Quinacrine for Treatment of Acute Myeloid Leukemia

Eriksson, Anna; Osterros, Albin; Hassan, Sadia Bashir; Gullbo, Joachim et al.

Part of Blood, 2014

Allogeneic Transplantation in First Remission Improves Outcome in Secondary Acute Myeloid Leukemia

Nilsson, Christer; Hulegardh, Erik; Lazarevic, Vladimir; Garelius, Hege et al.

Part of Blood, 2014

Second Malignancies Following Treatment of Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era

Gunnarsson, Niklas; Leif, Stenke; Höglund, Martin; Sandin, Fredrik et al.

Part of Blood, 2014

Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry

Höglund, Martin; Sandin, Fredrik; Hellstrom, Karin; Bjoreman, Mats et al.

Part of Blood, p. 1284-1292, 2013

DOI for Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry

Answer to "Letter to the Editor, Scandinavian Journal of Infectious Diseases"

Svensson, Tobias; Cherif, Honar; Höglund, Martin

Part of Scandinavian Journal of Infectious Diseases, p. 730-730, 2013

DOI for Answer to "Letter to the Editor, Scandinavian Journal of Infectious Diseases"

Clinical significance of serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukemia

Svensson, Tobias; Höglund, Martin; Cherif, Honar

Part of Scandinavian Journal of Infectious Diseases, p. 537-542, 2013

DOI for Clinical significance of serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukemia

Adjuvanted influenza a (H1N1) 2009 vaccine in patients with hematological diseases: good safety and immunogenicity even in chemotherapy-treated patients

Cherif, Honar; Höglund, Martin; Pauksens, Karlis

Part of European Journal of Haematology, p. 413-419, 2013

DOI for Adjuvanted influenza a (H1N1) 2009 vaccine in patients with hematological diseases: good safety and immunogenicity even in chemotherapy-treated patients

Cost-Utility Analysis Of Posaconazole Versus Fluconazole For Prevention Of Invasive Fungal Infections In Patients With Graft-Versus- Host Disease In Sweden

Lundberg, J. G.; Jensen, A. ; Bjorkholm, M.; Höglund, Martin et al.

Part of Value in Health, 2013

DOI for Cost-Utility Analysis Of Posaconazole Versus Fluconazole For Prevention Of Invasive Fungal Infections In Patients With Graft-Versus- Host Disease In Sweden

Decreased survival in normal karyotype AML with single-nucleotide polymorphisms in genes encoding the AraC metabolizing enzymes cytidine deaminase and 5 '-nucleotidase

Falk, Ingrid Jakobsen; Fyrberg, Anna; Paul, Esbjorn; Nahi, Hareth et al.

Part of American Journal of Hematology, p. 1001-1006, 2013

DOI for Decreased survival in normal karyotype AML with single-nucleotide polymorphisms in genes encoding the AraC metabolizing enzymes cytidine deaminase and 5 '-nucleotidase

Correlation between cytidine deaminase single nucleotide polymorphisms and in vitro drug sensitivity, DNA methylation and outcome in normal karyotype acute myelogenous leukemia

Falk, Ingrid Jakobsen; Fyrberg, Anna; Hermanson, Monica; Höglund, Martin et al.

Part of Cancer Research, 2013

DOI for Correlation between cytidine deaminase single nucleotide polymorphisms and in vitro drug sensitivity, DNA methylation and outcome in normal karyotype acute myelogenous leukemia

The novel tyrosine kinase inhibitor AKN-028 has significant antileukemic activity in cell lines and primary cultures of acute myeloid leukemia

Eriksson, Anna; Hermanson, Monica; Wickström, Malin; Lindhagen, Elin et al.

Part of Blood Cancer Journal, 2012

DOI for The novel tyrosine kinase inhibitor AKN-028 has significant antileukemic activity in cell lines and primary cultures of acute myeloid leukemia

In vitro evaluation of clinical activity and toxicity of anticancer drugs using tumor cells from patients and cells representing normal tissues

Haglund, Caroline; Åleskog, Anna; Nygren, Peter; Gullbo, Joachim et al.

Part of Cancer Chemotherapy and Pharmacology, p. 697-707, 2012

DOI for In vitro evaluation of clinical activity and toxicity of anticancer drugs using tumor cells from patients and cells representing normal tissues

Sex Differences in Fertility-Related Information Received by Young Adult Cancer Survivors

Armuand, Gabriela M.; Rodriguez-Wallberg, Kenny A.; Wettergren, Lena; Ahlgren, Johan et al.

Part of Journal of Clinical Oncology, p. 2147-2153, 2012

DOI for Sex Differences in Fertility-Related Information Received by Young Adult Cancer Survivors

Acute myeloid leukemia in the real world: why population-based registries are needed

Juliusson, Gunnar; Lazarevic, Vladimir; Hörstedt, Ann-Sofi; Hagberg, Oskar et al.

Part of Blood, p. 3890-3899, 2012

DOI for Acute myeloid leukemia in the real world: why population-based registries are needed

Influenza A H1N1 2009 Vaccine in Patients with Hematological Diseases: Good Safety and Immunogenicity Even in Heavily Chemotherapy-Treated Patients

Cherif, Honar; Höglund, Martin; Pauksens, Karlis

Part of Blood, p. 1054, 2012

Poor Outcome in Secondary Acute Myeloid Leukemia (AML): A First Report From the Population-Based Swedish Acute Leukemia Registry

Lehmann, Soren; Lazarevic, Vladimir; Horstedt, Ann-Sofi; Hulegardh, Erik et al.

Part of Blood, p. 130, 2012

Hematopoietic Stem Cell Transplantation Rates and Long-Term Survival in Acute Myeloid and Lymphoblastic Leukemia: Real-World Population-Based Data From the Swedish Acute Leukemia Registry 1997-2006

Juliusson, Gunnar; Karlsson, Karin; Lazarevic, Vladimir Lj; Wahlin, Anders et al.

Part of Cancer, p. 4238-4246, 2011

DOI for Hematopoietic Stem Cell Transplantation Rates and Long-Term Survival in Acute Myeloid and Lymphoblastic Leukemia: Real-World Population-Based Data From the Swedish Acute Leukemia Registry 1997-2006

Pregnancy and risk of acute myeloid leukaemia: a case-control study

Larfors, Gunnar; Höglund, Martin; Cnattingius, Sven

Part of European Journal of Haematology, p. 169-171, 2011

DOI for Pregnancy and risk of acute myeloid leukaemia: a case-control study

Identification of AKN-032, a novel 2-aminopyrazine tyrosine kinase inhibitor, with significant preclinical activity in acute myeloid leukemia

Eriksson, Anna; Höglund, Martin; Lindhagen, Elin; Åleskog, Anna et al.

Part of Biochemical Pharmacology, p. 1507-1516, 2010

DOI for Identification of AKN-032, a novel 2-aminopyrazine tyrosine kinase inhibitor, with significant preclinical activity in acute myeloid leukemia

Molecular monitoring and mutation analysis of patients with advanced phase CML and Ph plus ALL receiving dasatinib

Olsson-Strömberg, Ulla; Hermansson, Monica; Lundan, Tuija; Ohm, Anne-Charlotte et al.

Part of European Journal of Haematology, p. 399-404, 2010

DOI for Molecular monitoring and mutation analysis of patients with advanced phase CML and Ph plus ALL receiving dasatinib

Publications

Recent publications

All publications

Articles in journal

Articles, review/survey

Datasets

Manuscripts (preprints)